Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) dropped 1.2% during mid-day trading on Monday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Trading Down 1.2%
The stock has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81. The firm has a 50-day moving average of $24.38 and a 200 day moving average of $24.38.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:SWTUY) is a Stockholm-based biopharmaceutical company specializing in the development, manufacturing and commercialization of therapies for rare diseases and specialty care. The company’s portfolio spans treatments in hematology, immunology and metabolic disorders. Its research and development efforts focus on addressing unmet medical needs by advancing both proprietary and in-licensed drug candidates through clinical and regulatory pathways.
The company’s flagship offerings include clotting factor products for hemophilia, enzyme replacement therapies for lysosomal storage disorders and targeted immunomodulators for inflammatory conditions.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
